Charles River Laboratories International Inc
Charles River Laboratories International Inc (CRL) Option Chain
As of September 23, 2026, Charles River Laboratories International Inc is trading at $294.44, a +6.17% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 46.3%. IV Rank is 31%.
Read more
Tracking the CRL option chain helps you see every strike and expiry on Charles River Laboratories International Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Charles River Laboratories International Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of CRL options activity at a glance. Use our scanner to monitor the CRL option chain in real time and filter for the CRL options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For CRL stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the CRL option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where CRL stock options are being actively traded and where they are not.
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services.
The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company also provides contract vivarium operation services to biopharmaceutical clients. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Charles River Laboratories International Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen CRL options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of CRL stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryDiagnostics & Research
- SectorHealthcare
- IV percentile73.41% Elevated
- Market cap (M$)14,056
- 52 weeks high-2.92%
- 52 weeks low104.10%
- Analyst recommendationBuy
1.85 - Target price$301.79
2.50% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-04
- P/E—
- Future P/E23.06
- EPS (ttm)-4.85
- EPS growth next 5 years11.19%
As of September 23, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 42.80 | 51 | 50 | -6.99 | 24.44 | 16.00 | 18.90 | 270.00 | -2.64 | 8.30 | 10.40 | 0.00 | 9.35 | 100 | 417 | 57.20 |
| 54.74 | 262 | 168 | -1.99 | 14.44 | 11.30 | 13.60 | 280.00 | +0.96 | 13.00 | 15.20 | 0.00 | 14.10 | 70 | 77 | 45.26 |
| 65.88 | 531 | 4 | 3.71 | 4.44 | 7.30 | 9.00 | 290.00 | +4.57 | 18.60 | 22.20 | 0.00 | 20.40 | 173 | 130 | 34.12 |
| 75.47 | 77 | 25 | 5.15 | 0.00 | 3.80 | 6.50 | 300.00 | +8.17 | 25.80 | 28.90 | 5.56 | 21.79 | 8 | 4 | 24.53 |
| 83.16 | 134 | 0 | 3.38 | 0.00 | 1.65 | 5.10 | 310.00 | +11.78 | 33.70 | 36.70 | 15.56 | 19.64 | 0 | 0 | 16.84 |
As of September 23, 2026
Scan the full option chain in one place
Browse the full CRL option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→